Document is current
Any future updates will be listed below
-
Authors
Tokihiro, Jodie C.
Robertson, Ingrid H.
Gregucci, Denise
Shin, Albert
Michelini, Elisa
Nicholson, Tristan M.
Olanrewaju, Ayokunle O.
Theberge, Ashleigh B.
Berthier, Jean
Berthier, Erwin
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM128648)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (TL1TR002318, KL2TR002317)
- License Information
-
More Information
Article History
Received: 22 September 2024
Accepted: 4 December 2024
First Online: 30 December 2024
Declarations
:
: A.B.T. reports filing multiple patents through the University of Washington and A.B.T. received a gift to support research outside the submitted work from Ionis Pharmaceuticals. E.B. is an inventor on multiple patents filed by Tasso, Inc., the University of Washington, and the University of Wisconsin-Madison. T.M.N. has ownership in Tasso, Inc.; E.B. has ownership in Tasso, Inc., Salus Discovery, LLC, and Seabright, LLC and is employed by Tasso, Inc.; and A.B.T. has ownership in Seabright, LLC; however, this research is not related to these companies. The terms of this arrangement have been reviewed and approved by the University of Washington in accordance with its policies governing outside work and financial conflicts of interest in research. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
